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a  b  s  t  r  a  c  t
Rotavirus  (RoV)  and  Norovirus  (NoV)  are  the  main  causes  of viral  gastroenteritis.  Currently,  there  is no
validated  multiplex  real-time  PCR that  can  detect  and  quantify  RoV  and  NoV  simultaneously.  The aim  of
the study  was  to  develop,  validate,  and  internally  control  a multiplex  one-step  RT  real-time  PCR  to  detect
and quantify  RoV  and  NoV  in stool  samples.  PCR  sensitivity  was  assessed  by  comparing  ampliﬁcation
against  the  current  gold  standard,  enzyme  immunoassay  (EIA),  on  stool  samples  from  94 individuals  with
diarrhea  and  94  individuals  without  diarrhea.  PCR  detected  10%  more  RoV  positive  samples  than  EIA in
stools  samples  from  patients  with  diarrhea.  PCR  detected  23%  more  NoV  genogroup  II  positive  samples
from  individuals  with  diarrhea  and  9%  more  from  individuals  without  diarrhea  than  EIA, respectively.orovirus
eal-time PCR
uantitation
nternally controlled
Genotyping  of  the  PCR  positive/EIA  negative  samples  suggested  the  higher  rate  of PCR  positivity,  in
comparison  to  EIA,  was  due  to  increased  sensitivity,  rather  than  nonspeciﬁc  hybridization.  Quantitation
demonstrated  that  the  viral  loads  of  RoV  and  NoV  in the  stools  of diarrheal  patients  were  an  order  of
magnitude  greater  than  in  individuals  without  diarrhea.  This  internally  controlled  real-time  PCR  method
is robust,  exhibits  a  high  degree  of  reproducibility,  and  may  have  a  greater  utility  and  sensitivity  than
commercial  EIA  kits.. Introduction
Diarrhea remains a major cause of childhood morbidity and
ortality globally (Thapar et al., 2004; Wardlaw et al., 2010),
ith the vast majority of the 2 billion annual infections and
.5 million resulting deaths occurring in low and middle-income
ountries. Viruses, speciﬁcally Rotavirus A (RoV) and genogroup
 and II Norovirus (NoVI and II) are predominant causes of
iral gastroenteritis worldwide, and are responsible for over
0% of all cases of diarrhea in developing countries (Davidson
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et al., 2002; Patel et al., 2008; Widdowson et al., 2009). A vari-
ety of techniques are used to detect RoV and NoV in stool
samples, including electron microscopy (Caul, 1996a,b), latex
agglutination (Lee et al., 2010), PCR ampliﬁcation, and enzyme
immunoassay (EIA) (Jiang et al., 2000). Commercial EIA kits
are the most common methods used for diagnosis, as they
offer simplicity and good speciﬁcity, but may lack overall sen-
sitivity in some settings (Barreira et al., 2010; Ramani et al.,
2010). Typically, the sensitivity of viral detection in biological
material can be increased using molecular methods (Freeman
et al., 2008; Kageyama et al., 2003), with real-time reverse
transcriptase (RT) PCR having advantages over conventional RT-
PCR (Freeman et al., 2008; Trujillo et al., 2006). The aim of
Open access under CC BY license.the study was to develop and validate a multiplex one-step RT
real-time PCR, controlled internally, to detect and quantify RoV
and NoV in stool samples from individuals with and without
diarrhea.
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Table 1
Sequences and concentrations of primers and probes used in this study.
Viral target Target region/amplicon size Primer/probe name Sequencesa Final conc. (M) Reference
RoV Non-structural protein
3 (NSP3)/87 bp
NVP3-FDeg ACC ATC TWC  ACR TRA CCC
TC
1
NVP3-R1 GGT CAC ATA ACG CCC CTA
TA
1  Freeman et al. (2008)
NVP3-Probe FAM-ATG AGC ACA ATA
GTT AAA AGC TAA CAC TGT
CAA-BHQ1
0.125
NoVII ORF1-ORF2
junction/98 bp
Cog 2F CAR GAR BCN ATG TTY AGR
TGG ATG AG
1
Cog  2R TCG ACG CCA TCT TCA TTC
ACA
1 Trujillo et al. (2006)
Ring 2 Cyan500–TGG GAG GGC
GAT CGC AAT CT–BHQ1
0.125
NoVI ORF1-ORF2
junction/84 bp
Cog 1F CGY TGG ATG CGI TTY CAT
GA
1
Cog  1R CTT AGA CGC CAT CAT CAT
TYA C
1 Trujillo et al. (2006)
Ring 1 C FAM–AGA TYG CGI TCI CCT
GTC CA–BHQ1
0.125
EAV EAV-F CAT CTC TTG CTT TGC TCC
TTA G
0.2
EAV-R AGC CGC ACC TTC ACA TTG 0.2 Hue et al. (2011)
EAV-probe Cyan500–CGC GCT CGC
TGT CAG AAC AAC ATT ATT
GC
0.05
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(a W = T, U, A; R = A, G; Y = C, T; B = C, G, T; N = any; I = inosine.
. Materials and methods
.1. Ethics statement
This study was conducted according to the principles expressed
n the Declaration of Helsinki, and was approved by the ethical
eview boards of the Hospital for Tropical Diseases (HTD), Chil-
ren’s Hospital 1 (CH1) and Children’s Hospital 2 (CH2) in Ho Chi
inh City in Viet Nam, and the Oxford Tropical Research Ethics
ommittee (OxTREC) in the United Kingdom. An informed consent
orm, signed by a parent or guardian, was required for participation.
.2. Stool samples and sample processing
Stool samples were obtained from a group of symptomatic
hildren (with diarrhea) and a group of asymptomatic children
without diarrhea). The symptomatic group consisted of 217 chil-
ren, aged between 0 and 60 months, admitted to CH1, CH2 or
TD between May  2009 and April 2010 with acute watery diarrhea
deﬁned as three or more loose stools without blood within a 24 h
eriod). The asymptomatic group consisted of 277 children, aged
etween 0 and 60, attending CH2 for health checks between May
009 and April 2010 without diarrhea. Stool specimens were col-
ected from all participants within 24 h of hospital admission and
rior to antimicrobial treatment. All samples were stored at 4 ◦C
efore transportation to the laboratory on the same day as collec-
ion. Samples were assayed to detect RoV and NoV using ProspecT
otavirus and IDEIA Norovirus EIA tests following manufacturer’s
ecommendations (Oxoid, United Kingdom). Two  aliquots of each
ample were stored at −80 ◦C as 10% suspensions in distilled phos-
hate buffered saline (PBS).
.3. Equine arterititis virus (EAV)EAV was added to all samples prior to nucleic acid extraction
s an internal control (Hue et al., 2011). Aliquots of post culturing
upernatant containing EAV were prepared as described previously
Hue et al., 2011; Scheltinga et al., 2005). The precise amount ofC CAC AGC GCG–BHQ3
virus added to the stool samples was  assessed by PCR titration.
The ﬁnal EAV dilution used in the PCR assay produced Cp values
between 30 and 33. Ampliﬁcation runs that did not produce a Cp
value within this range for EAV were discarded and samples were
subjected to a secondary extraction and ampliﬁcation.
2.4. NoV and RoV PCR ampliﬁcation primers and probes
Primers, probes and their optimal concentrations are described
in Table 1. Brieﬂy, the RoV primers targeted the gene encoding
non-structural protein 3 (NSP3) (Freeman et al., 2008), and the
probe incorporated a FAM reporter and a BHQ1 quencher. The NoV
primers and probes targeted the ORF1-ORF2 junction of NoV I and
NoVII (Trujillo et al., 2006). The reporter of the NoVII probe was
adapted from the probe published in Trujillo et al. (2006) from
Quasar 670 (red) to Cyan 500 (blue–green) as these probes have
a higher performance using the LightCycler format and as a conse-
quence of the Cy5 tag of the internal control. The primers and probe
for EAV were as previously described (Hue et al., 2011; Scheltinga
et al., 2005).
2.5. Nucleic acid extractions and one-step RT Real-time PCR
Nucleic acid was  extracted from bacterial and viral sources using
the Wizard Nucleic Acid Puriﬁcation Kit (Promega, USA) and the
QIAamp Viral RNA Mini Kit (QIAGEN, USA), respectively. Nucleic
acid preparations were diluted to a concentration of 20 ng/l, and
stored at −20 ◦C. For viral RNA extractions from stool, 140 l of stool
was  inoculated with 20 l of EAV and subjected to an automated
extraction on a MagNA Pure 96 nucleic extraction system using
the MagNA Pure 96 DNA and the Viral NA Small Volume Kit (Roche
applied sciences, UK), according to the manufacturers recommen-
dations. PCR ampliﬁcations were performed using RNA Master
Hydrolysis Probes (Roche applied sciences, UK), and optimized with
1.4 l of activator on a LightCycler 480II (Roche applied sciences,
UK). Thermal cycling was initiated at 61 ◦C for 3 min  for reverse
transcription; plates were cooled on ice for 2 min, and ampliﬁed
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Table 2
Assessment of the reproducibility (CV%) of the assays on diluted plasmid DNA containing cloned target sequences.
Target and variable Target concentration
5 × 108 5 × 107 5 × 106 5 × 105 5 × 104 5 × 103 5 × 102 5 × 101 5 × 100
RoV
Intra-assay variationa 4.07 0.2 0.77 1.87 1.43 1.12 1.14 – –
Inter-assay variationb 4.91 5.22 1.83 2.77 0.98 0.66 1.43 – –
NovI
Intra-assay variation 2.06 0.3 0.81 0.55 0.94 0.3 0.95 1.96 –
Inter-assay variation 1.73 3.28 2.01 0.5 0.79 1.68 2 1.64 –
NoVII
Intra-assay variation 0.51 0.71 0.58 0.58 0.27 0.23 0.41 0.36 1.02
Inter-assay variation 3.42 1.13 1.24 0.9 3.36 2.77 2.54 2.56 3.02
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b Inter-assay variation was calculated by comparing variation in Cp value on four
or 5 min  at 95 ◦C, followed by 45 cycles at 95 ◦C for 5 s and 60 ◦C
or 45 s.
.6. Construction of plasmids containing target sequences
PCR amplicons for all target loci were produced using the
T real-time PCR procedure without probe. Amplicons were
loned into pCR 2.1-TOPO (Invitrogen applied biosystems, UK),
ollowing the manufacturers guidelines. Plasmid DNA, with
loned target DNA sequences, was puriﬁed, and concentrations
ere calculated using a NanoDrop spectrophotometer (Thermo-
cientiﬁc, UK). DNA concentrations were converted to copy
umber using the formula: mol/g × molecules/mol = molecules/g,
ia a DNA copy number calculator (http://www.uri.edu/research/
sc/resources/cndna.html). Ten-fold serial dilutions of plasmid
NA containing the cloned target insert were used as an external
tandard for all quantitative one-step Real-time RT PCR experi-
ents.
.7. Detection limits and ampliﬁcation interpretation
Ten-fold serial dilutions of plasmid DNA containing the cloned
arget insert, with concentrations ranging from 5 ×100 to 5 × 103
opies per reaction, were ampliﬁed on ﬁve consecutive days. Ten
eplicates were performed daily. The detection limit was  calculated
sing ﬁfty individual Cp values and set at the target DNA concen-
ration at which a positive PCR signal was produced in 95% or more
f the samples tested.
Accurate DNA extraction and ampliﬁcation was  conﬁrmed by
he production of a signal from the EAV internal control. A negative
CR result was concluded if negative controls were negative, if the
nternal control showed the predicted Cp value, and if a reporter
ignal for target sequences could not be detected (Cp > 40). Data
as deemed non-interpretable when the negative control demon-
trated contamination and/or the internal control did not yield a
ufﬁcient Cp value.
.8. Reproducibility, linearity and efﬁciency
The co-efﬁcient of variance (CV%) was calculated by assessing
he Cp value deviation of selected plasmid DNA concentrations
cross multiple ampliﬁcations. Intra-assay reproducibility was
etermined by comparing the Cp values generated in the same
un of four replicates over each plasmid concentration. Inter-assay
eproducibility was assessed by comparing the Cp values gener-
ted by four replicates of each plasmid concentration each day over
 period of four days. Linearity was assessed from the Cp values
f 10-fold serial dilutions of plasmid DNA containing cloned tar-
et sequences (concentrations 5 × 100 to 5 × 108) and calculatingp value on four concurrently run assays.
endently run assays.
their linear regression. Efﬁciency was  calculated from the slope
of the standard curve using the formula: Efﬁciency = 10(−1/slope)−1,
according to the methods of Rasmussen (2001).
Data were exported into Microsoft Excel (Microsoft, USA), and
analyzed using STATA 9.2 (StataCorp, College Station TX, USA); spe-
ciﬁc statistical tests used are outlined in the results.
3. Results
3.1. Analytical speciﬁcity and detection limits
Two  one-step RT real-time PCR assays were developed. One
PCR contained primers and probes detecting RoV, NoVII and EAV,
the other contained primers and probes to detect NoVI and EAV.
Plasmid DNA containing RoV, NoVI and NoVII target sequences
were used as positive ampliﬁcation controls. Both PCR assays were
tested on nucleic acid extracted from 45 gastrointestinal organisms,
including enterovirus, Escherichia coli, Campylobacter, Shigella spp.,
Salmonella spp. and Klebsiella spp.  Neither assay demonstrated
any nonspeciﬁc ampliﬁcation with any target nucleic acid from
any of the organisms tested. The NoVI, NoVII and RoV Cp values
obtained during multiplex PCR remained unchanged from mono-
ampliﬁcation at the same concentration. The detection limits of the
assays were 500, 5 and 50 copies of the cloned target sequence for
RoV, NoVII and NoVI, respectively.
3.2. Reproducibility and linearity
Table 2 shows the results from a series of consecutive standard
curve experiments. These data demonstrate overall performance,
intra-assay variation and inter-assay variation of the PCRs. The
intra-assay CV and the inter-assay CV across the three targets
ranged from 0.2% to 4.07% and 0.5% to 5.22%, respectively, with
target copy numbers from 5 × 100 to 5 × 108 copies per reaction.
Linearity was assessed by Cp values generated from ampliﬁca-
tion of eight ten-fold serial dilutions. The linear regressions of the
three standard curves were R2 = 0.992 for RoV, R2 = 0.992 for NoVI
and R2 = 0.999 for NoVII, indicating a signiﬁcant linear correlation
between Cp value and amount of nucleic acid over a range of con-
centrations. The efﬁciencies of the ampliﬁcations were 94% for RoV
(95% CI; 93–98%), 89% for NoVI (95% CI; 87–91%) and 96% for NovII
(95% CI; 94–98%).
3.3. Comparison of EIAs and one-step RT real-time PCRsThe performance and sensitivity of the PCR assays were
evaluated against EIA (Table 3). Sensitivity was  compared using
ten-fold dilutions off three RoV EIA+/PCR+ samples and three
NoV EIA+/PCR+ samples. For the RoV positive samples, all were
T.T.N. Dung et al. / Journal of Virological Methods 187 (2013) 138– 143 141
Table 3
Analytical comparison of the performance of real-time PCR against EIA.
Viral sample Test Concentration of diluted RNA
Neat 10−1 10−2 10−3 10−4
RoV samples (sample ID)
30,217 RT-PCR 15.32 18.08 21.39 24.68 27.89
EIA Positive Positive Positive Negative Negative
30,205 RT-PCR 17.8 19.48 22.68 26.29 29.52
EIA Positive Positive Positive Negative Negative
30,453 RT-PCR 17.73 20.6 23.65 26.9 29.43
EIA  Positive Positive Negative Negative Negative
NoV  samples (sample ID)
20,154 RT-PCR 15.35 17.7 21.54 25.43 30.02
EIA Positive Positive Positive Negative Negative
20,614 RT-PCR 17.52 20.22 24.23 27.4 31.4
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RoV have been well characterized and were originally designed by
Pang et al. (2004) and Kageyama et al. (2003) for RoV and NoV,
respectively. These methods have evolved and the primers and
probes have been modiﬁed, incorporating degenerate nucleotides
Fig. 1. The viral load of RoV, NoVI and NoVII in stool samples. Box plots showing theEIA  Positive N
20,172 RT-PCR 18.31 2
EIA  Positive N
CR+/EIA+ at the 10−1 dilution and all were PCR+/EIA− at the
0−3 dilution. For the NoVII positive samples, all were PCR+/EIA−
t the 10−3 dilution. Nucleic acid from RoV PCR+ and NoV PCR+
amples were combined on ten occasions to assess potential
mpliﬁcation inhibition induced by cross-reactivity. The Cp values
ere unchanged in samples containing RoV and NoV from those
ontaining only RoV or NoV.
Ninety-four stool samples from patients with diarrhea and 94
tool samples from patients without diarrhea were investigated
y EIA and PCR for RoV and NoV (Table 4). The EIA+ results
orresponded precisely with qualitative PCR results for RoV and
oVI/II. In the children with diarrhea, 10/94 (10.6%) samples were
CR+/EIA− for RoV and 22/94 (23.4%) were PCR+/EIA− for NoV.
n the children without diarrhea, 0/94 samples were PCR+/EIA−
or RoV and 7/94 (7.4%) samples were PCR+/EIA− for NoV. The
oV PCR+/EIA+ Cp values samples were compared with the RoV
CR+/EIA− Cp values. The median Cp value from the RoV PCR+/EIA+
amples was 15.3; the median Cp value from the RoV PCR+/EIA−
amples was signiﬁcantly higher at 22.5 (p < 0.0001; two-tailed t-
est). The presence of RoV and NoV in the PCR+/EIA− samples was
onﬁrmed by PCR ampliﬁcation of the VP7 and VP4 genes in the
oV+ samples and VP1 in the NoV+ samples (Yan et al., 2003;
omara et al., 2001). All produced the expected ampliﬁcations.
equencing of the resulting amplicons conﬁrmed the real-time RT
CR results, demonstrating these samples contained either GI RoV
r GII.4 NoV, respectively (data not shown).
.4. Quantitative PCR results
The PCRs were used to assess prevalence and quantitate NoV
nd RoV in stool samples from 217 children with diarrhea and 277
ithout diarrhea (including the 94 samples used to assess PCR sen-
itivity against EIA) (Fig. 1). From the samples from children with
iarrhea, 101/217 (46.5%) were positive for RoV, 113/217 (52%)
ere positive for NoVII, 22/217 (10.1%) were positive for both RoV
nd NoVII and 0/217 were positive for NoVI. From the samples from
hildren without diarrhea, 12/277 (4.3%) were positive for RoV,
5/277 (9%) were positive for NoVII and 5/277 (1.8%) were positive
or NoVI.
Cp values were converted to copy number by use of a standard
urve. The RoV loads in the samples from children with diarrhea
ere signiﬁcantly higher than in the samples from children with-
ut diarrhea (with diarrhea; median = 10.06 log/RNA copies/ml
range; 5.56–12.49), without diarrhea; median = 8.33 log/RNA
opies/ml (range; 5.43–10.52), p < 0.001, two tailed t-test) (Fig. 1).
oVII loads in the samples from children with diarrhea were
igniﬁcantly higher than in the samples from children withoute Negative Negative Negative
24.76 28.18 32.8
e Negative Negative Negative
diarrhea (with diarrhea; median = 6.85 log/RNA copies/ml (range;
2.89–9.71), without diarrhea; median = 5.07 log/RNA copies/ml
(range; 3.63–9.16), p = 0.02, two tailed t-test). Only samples from
children without diarrhea tested positive for NoVI, with the viral
load (log/RNA copies/ml) ranging from 3.2 to 4.88; median 3.56.
4. Discussion
Here we  have developed, validated and used a real-time RT-PCR
assay to detect and quantify the two major causes of viral diar-
rhea. The performance of the validated assays was controlled by
the inclusion of a standardized internal control. The internal con-
trol addition permits assurance of extraction, ampliﬁcation, and
quantitation, making these assays a robust for use in a clinical
microbiology laboratory. Furthermore, these assays were tested
throughout a large range of nucleic acid concentrations, producing
reliable and reproducible quantitative results.
The target regions for the primers and probes for NoV andmedian and interquartile range of RoV, NoVI and NoVII viral copy number in stool
samples from children with and without diarrhea in HCMC, Viet Nam. Statistical
signiﬁcance between the samples from children with and without diarrhea was cal-
culated using a two-tailed t-test; signiﬁcant variation in viral copy number between
samples is denoted at the head of the ﬁgure; signiﬁcant p values are shown.
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Table 4
Performance of RT Real-time PCR in comparison to EIA.
Assay result Diarrheal group (n = 94) Non-diarrheal group (n = 94)
Real-time PCR EIA RoV NoV RoV NoV
− − 50 47 94 86
+  + 34 25 0 1
− + 0 0 0 0
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Increase in sensitivity 10.6% (10/94) 
o account for known diversity within the target regions (Freeman
t al., 2008; Trujillo et al., 2006). However, the true speciﬁcity and
ensitivity of the modiﬁed primers and probes have never been
irectly assessed. The optimized conditions of the virus speciﬁc
CRs presented above demonstrated an increase in sensitivity over
he current universal gold standard, EIA. The PCR method consis-
ently detected NoV and RoV in lower concentrations than EIA.
owever, corroborating this increase in sensitivity over the gold
tandard is a challenge, as nonspeciﬁc hybridization at low DNA
oncentrations may  induce a comparable result. Yet, the propor-
ion of PCR+/EIA− samples was greater in the samples from children
ith diarrhea than the samples from children without diarrhea and
onventional PCR and amplicon sequencing conﬁrmed the real-
ime RT PCR data. Furthermore, the PCR+/EIA− samples exhibited
igniﬁcantly higher Cp values than the PCR+/EIA+ samples, cor-
esponding with the stool dilution experiments. Taken together,
hese data strongly suggest that the PCR assays are amplifying
ucleic acid from RoV and NoV exclusively, rather than demon-
trating cross-hybridization.
A noteworthy observation from the development of these assays
as the ability to detect NoV and RoV in the stools of individuals
ith diarrhea. NoV and RoV infections without diarrheal symptoms
ave been described previously (O’Ryan et al., 2009; Walther et al.,
983; Zhang et al., 2011), and due to the design of the study pre-
ented above, it is impossible to assess the role of these individuals
n Ho Chi Minh City. However, NoV and RoV the stools of individ-
als without diarrhea may  reﬂect a true asymptomatic infection or
onger-term shedding after a symptomatic infection (Eiden et al.,
988; Phillips et al., 2009). Furthermore, as the incubation period
or NoV and RoV is approximately two days (Bernstein, 2009; Glass,
arashar, and Estes, 2009), and both pathogens have an excep-
ionally low infective dose (Glass et al., 2009) (Leung, Kellner, and
avies, 2005; Leung and Pai, 1988), these PCR+ individuals may  be
n the incubation period. The PCR presented above can be used to
ddress this phenomenon in a prospective study.
Collectively, RoV and NoV are the leading causes of acute viral
iarrhea and are a substantial cause of mortality in children under
ve years old worldwide. Co-infection with both pathogens is com-
on  and assays have been developed for the detection of multiple
auses of viral gastroenteritis, including NoV, RoV, astrovirus and
denovirus (Feeney et al., 2011; van Maarseveen et al., 2010). The
ork presented above augments the PCR methods of Feeney et al.
2011) and van Maarseveen et al. (2010),  describing an increase
n sensitive and offering a reliable solution or alternative to the
iagnosis of these pathogens. The addition of an internal control
eans that these methods are transferable, and can be used for
iagnosis, environmental sampling and epidemiological screening.
urthermore, the ability to perform quantitation permits a greater
egree of utility, facilitating an understanding of the dynamics of
iruses prior to, during and post-infection. In conclusion, the work
resented above outlines an internally controlled multiplex real-
ime RT PCR assay to detect RoV and NoV in stool samples. The
ethodology is robust, exhibits a high degree of reproducibility
nd may  have a greater utility and sensitivity that commercial EIA
its.22 0 7
23.4% (22/94) 0% (0/94) 7.4% (7/94)
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